BioSpace News Archive

The data is used to help biopharma in the performance evaluation of their sites and to help set realistic site level enrollment plans.

[01-November-2017] MINNEAPOLIS and ST. PAUL, Minn., Nov. 1, 2017 /PRNewswire/ -- Newly discovered genetic markers in osteosarcoma tumors could help tailor a more precise treatment, improving survival rates and quality of life for children and young adults with the disease. The study , recently published in Cancer Research , analyzed osteosarcoma tumor profiles from mice, dogs and hu

The presentation reports on the effect of BGB324 treatment on blood plasma proteins and their relationship to treatment outcome, as a means of identifying possible biomarkers for patient selection and the development of companion diagnostics.

3F Mosquito Fragrance (“3F Mosquito”), which is made up of specialized oils sourced from botanicals that mosquitoes avoid, has shown 100% repellency against mosquitoes in laboratory testing.

Braeburn today announced that the U.S. FDA Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee jointly voted 17-3 recommending approval of CAM2038, .

Total revenue for the third quarter of 2017 increased 3% over the third quarter of 2016 to $50.9 million.

Revenue grew to $184.6 million for the third quarter of 2017, an increase of 24% from the $148.6 million in revenue for the same quarter in 2016.

During the third quarter of 2017, CABOMETYX generated $90.4 million in net product revenue.

This transaction includes Teva’s manufacturing facility in Buffalo, NY, which produces PARAGARD exclusively.

The UEGW meeting takes place from October 28 to November 1, 2017 in Barcelona, Spain, and is hosted by the United European Gastroenterology (UEG), a professional non-profit organization combining all the leading European societies concerned with digestive health